Early tumor shrinkage improves survival in pancreatic cancer

Early tumor shrinkage improves survival in pancreatic cancer

For patients with recurrent and metastatic pancreatic cancer who received chemotherapy as a first-line treatment, early tumor shrinkage correlated with an improved rate of progression-free survival and overall survival.“Despite the availability of various types of treatment regimens for advanced pancreatic cancer (PC), there is a lack of factors that define the precocity or depth of tumor regression and can reliably anticipate prognosis as the first-line of therapy. Early tumor shrinkage (ETS) implies a depletion ( 20%) in tumor burden. … Depth of response (DpR) is classified as theRead More

Share on facebook
Share on twitter
Share on linkedin